Physician

Maria Rizkallah Boustani, MD

According to 2025 Medicare claims, Maria Boustani, MD (NPI: 1518917632) practices pulmonary disease in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is RHEUMATOLOGY AND PULMONARY CLINIC PLLC (NPI: 1467439463; TIN: 550775651) and primary practice location at 25801-2805.

Boustani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 4,292 HCPCS/CPT codes, and received $215,945 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,905 prescription claims across 472 beneficiaries totaling $3,179,972 in drug costs, led by Glassia (Alpha-1-Proteinase Inhibitor). DME data shows 2,201 claims. Open Payments data shows 97 records totaling $212,794. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,773,596 to $3,179,972. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	955	5,485	$232,949
2016	976	5,684	$233,790
2017	902	4,829	$200,272
2018	900	5,049	$200,798
2019	866	4,687	$215,593
2020	795	3,574	$175,825
2021	743	3,687	$205,806
2022	659	2,942	$160,772
2023	672	3,874	$207,449
2024	602	4,292	$215,945

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	390	4,500	$1,773,596
2016	378	3,903	$2,650,346
2017	366	3,214	$2,337,462
2018	351	3,062	$2,213,383
2019	403	2,945	$3,076,897
2020	380	2,861	$3,094,616
2021	363	2,783	$3,099,069
2022	391	2,677	$3,062,079
2023	430	2,822	$3,099,024
2024	472	2,905	$3,179,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	776	2,827	$247,606
2016	760	3,030	$176,675
2017	577	2,322	$165,415
2018	636	2,515	$168,338
2019	675	2,392	$188,509
2020	804	2,495	$200,101
2021	918	2,760	$229,390
2022	903	2,642	$257,479
2023	819	2,648	$283,744
2024	746	2,201	$203,226

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	350	749	$89
94729	Test to examine how well the lungs exchange gases	321	339	$37
94726	Test to determine lung volumes using sensors	324	342	$36
94060	Test to measure expiratory airflow and volume changes before and after medication administration	324	342	$25
71046	X-ray of chest, 2 views	368	494	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Glassia	Alpha-1-Proteinase Inhibitor	107	2,961	$1,334,790
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	430	17,940	$376,479
Ofev	Nintedanib Esylate	20	600	$261,657
Aralast Np	Alpha-1-Proteinase Inhibitor	18	504	$177,130
Zemaira	Alpha-1-Proteinase Inhibitor	18	490	$152,642

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	57	$57,864
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	13	69	$52,263
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	45	284	$21,798
A7030	Full face mask used with positive airway pressure device, each	N	59	113	$10,079
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	19	98	$9,758

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$13,829	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	36	$198,964	SANOFI US SERVICES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maria Rizkallah Boustani, MD?

Tedicare shows public-source Medicare data for Maria Rizkallah Boustani, MD (NPI 1518917632), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maria Rizkallah Boustani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maria Rizkallah Boustani, MD?

Maria Rizkallah Boustani, MD is linked to RHEUMATOLOGY AND PULMONARY CLINIC PLLC (billing NPI 1467439463) in the available physician profile data.

Does Maria Rizkallah Boustani, MD have Open Payments data?

Maria Rizkallah Boustani, MD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.